حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
Cryofocus Medtech (Shanghai)
6922Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, develops, produces, and sells minimally-invasive interventional cryotherapy products in the People's Republic of China. The company develops products in the areas of vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases. Its products include Bladder Cryoablation System, a cryotherapy device for the treatment of non-muscle-invasive bladder cancer; pulmonary nodule localization needle for CT-guided localization of lung nodules; endoscopic clip for anastomosis for the closure of soft tissue in digestive tract; and laparoscopic single port multi-channel access platform for laparoscopic surgery. The company's products also comprise wound retractors for small incision surgery and minimally invasive surgery; ureteral dilation balloon catheter for ureteral stricture; laparoscopic biopsy bag for biopsy; and laparoscopic surgical instrument for laparoscopy application. The company was incorporated in 2013 and is based in Shanghai, the People's Republic of China. Address: Building 15, Shanghai, China, 200120
Analytics
سعر الهدف في وول ستريت
217.46 HKDنسبة السعر إلى الأرباح
–العائد الربحي
–السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية 6922
تحليلات الأرباح 6922
نمو الأرباح على مدى 5 سنوات
–النمو المستمر
–معدل الدفع 5 سنوات في المتوسط
–تاريخ الأرباح 6922
تقييم الأسهم 6922
المالية 6922
نتائج | 2019 | ديناميات |